SL 483
Pill imprint SL 483 has been identified as Theophylline extended-release 100 mg.
Theophylline is used in the treatment of asthma, maintenance; apnea of prematurity; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy.
Theophylline 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Theophylline extended-release Images
- Imprint:
-
SL 483
- Strength:
- 100 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
lactose anhydrous
magnesium stearate
povidone k30
- Drug Class:
- Methylxanthines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sidmak
- National Drug Code (NDC):
- 50111-0483
Advertisement
More Theophylline Extended-Release resources
- Theophylline (Wolters Kluwer)
- Theophylline Elixir (Wolters Kluwer)
- Theophylline Sustained-Release Capsules (Wolters Kluwer)
- Theophylline Sustained-Release Tablets (Wolters Kluwer)
- theophylline (Cerner Multum)
- Norphyl (Micromedex) - Includes Dosage Information
- Phyllocontin (Micromedex) - Includes Dosage Information
- theophylline (Micromedex) - Includes Dosage Information
- theophylline Intravenous (Micromedex) - Includes Dosage Information
- Theophylline (FDA)
- Theophylline Elixir (FDA)
- Theophylline Oral Solution (FDA)
- Theophylline in Dextrose (FDA)
- Theophylline (Wolters Kluwer)
Search Again
